Company Overview
INMUNE BIO, INC.
INMBRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
0M
2025 FY
Net Income
-46M
2025 FY
Shares Outstanding
25M
2025 FY
EPS
-1.86USD
2025 FY
Company Information
SIC Code
2836
CIK Code
1711754
Exchange
Nasdaq
Location
US